Moderna: AI Leader In Medicine
Cancer and Herpes are only two potential growth catalysts for Moderna. The company has a long runway for growth, with over 45 developing drugs and 38 ongoing clinical trials. There's a buffet selection of diseases, even though most of these trials will fail. Getting 10-15 drugs approved in the next five years could give Moderna a higher market cap than any other biotech company.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment